Skip to main content
. 2021 Apr 14;26(8):2264. doi: 10.3390/molecules26082264

Figure 3.

Figure 3

Synergistic effect of MEL and PLA2 on the viability of HCT116 cell lines. HCT116 cells were treated with PLA2 (A) (10 µg/mL), or (B) (50 µg/mL) and MEL (14.05 µg/mL) simultaneously or after a pretreatment delay. Pretreatment delay corresponds to addition of the MEL 30 min before the PLA2. The data are expressed as the means ± SD (n = 3), * p < 0.05, ** p < 0.01, *** p < 0.001 compared with untreated cells (control).